Article (Scientific journals)
Management of metabolic syndrome and associated cardiovascular risk factors.
De Flines, Jenny; Scheen, André
2010In Acta Gastro-Enterologica Belgica, 73 (2), p. 261-6
Peer Reviewed verified by ORBi
 

Files


Full Text
Management of metabolic syndrome and associated cardiovascular risk factors.pdf
Publisher postprint (119.48 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
metabolic syndrome; lifestyle, drug therapy; obesity; cardiovascular risk factor; insulin resistance
Abstract :
[en] Patients with metabolic syndrome have a 1.5- to 3-fold increase in the risk of coronary heart disease and stroke. The association between metabolic syndrome and cardiovascular diseases raises important questions about the underlying pathological processes, especially for designing targeted therapeutic interventions. Cardiovascular risk reduction in individuals with metabolic syndrome should include at least three levels of interventions: 1) control of obesity, unhealthy diet and lack of physical activity; 2) control of the individual components of metabolic syndrome, especially atherogenic dyslipidaemia, hypertension, dysglycaemia and prothrombotic state; and 3) control of insulin resistance, a defect closely linked to metabolic syndrome. Metabolic syndrome generally precedes and is often associated with type 2 diabetes. Because of this intimate relationship, appropriate management of metabolic syndrome should be able to prevent the progression from impaired glucose tolerance to frank diabetes and thus to prevent type 2 diabetes, another important cardiovascular risk factor. The importance of prevention of diabetes in high-risk individuals (such as people with metabolic syndrome are) is highlighted by the substantial and worldwide increase in the prevalence of type 2 diabetes in recent years. Owing to the complex pathophysiology and phenotypic expression of metabolic syndrome, lifestyle changes are crucial as they are able to positively and simultaneously influence almost all components of the syndrome. If such measures are not sufficient or not adequately followed, a pharmacological intervention may be considered. However, no official guidelines are available yet concerning the pharmacological management of individuals with metabolic syndrome.
Disciplines :
Cardiovascular & respiratory systems
Endocrinology, metabolism & nutrition
Author, co-author :
De Flines, Jenny ;  Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
English
Title :
Management of metabolic syndrome and associated cardiovascular risk factors.
Publication date :
2010
Journal title :
Acta Gastro-Enterologica Belgica
ISSN :
0001-5644
eISSN :
1784-3227
Publisher :
Acta Medica Belgica, Bruxelles, Belgium
Volume :
73
Issue :
2
Pages :
261-6
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 August 2010

Statistics


Number of views
101 (5 by ULiège)
Number of downloads
3 (1 by ULiège)

Scopus citations®
 
21
Scopus citations®
without self-citations
19

Bibliography


Similar publications



Contact ORBi